Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Aldoss

Showing results (131-140 of 189) with videos related to

Pageof 19
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2017
Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance RituximabMatthew G Mei, Thai M Cao, Lu Chen, et al.
Science Translational Medicine|September 27, 2019
CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignanciesHong Qin, Zhenyuan Dong, Xiuli Wang, et al.
Leukemia Research|August 29, 2024
Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantationAmrita Desai, Yazeed Samara, Dongyun Yang, et al.
Bone Marrow Transplantation|August 15, 2024
Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settingsSalman Otoukesh, Dongyun Yang, Sally Mokhtari, et al.
Bone Marrow Transplantation|November 18, 2025
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxisAmandeep Salhotra, Dongyun Yang, Monzr M Al Malki, et al.
Cancer|December 1, 2020
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemiaTalha Badar, Aniko Szabo, Shira Dinner, et al.
Transplantation and Cellular Therapy|July 10, 2026
Impact of prior CAR T-cell treatment on graft-vs-host disease and non-relapse mortality after allogeneic transplantationTamer Othman, Dongyun Yang, Geoffrey Shouse, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 20, 2019
Long-Term Outcomes of Patients with Acute Myelogenous Leukemia Treated with Myeloablative Fractionated Total Body Irradiation TBI-Based Conditioning with a Tacrolimus- and Sirolimus-Based Graft-versus-Host Disease Prophylaxis Regimen: 6-Year Follow-Up from a Single CenterAmandeep Salhotra, Susanta Hui, Dongyun Yang, et al.
Transplantation and Cellular Therapy|May 14, 2023
Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease ProphylaxisJanny M Yao, Salman Otoukesh, Hanna Kim, et al.
Nature|March 16, 2023
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemiaGhayas C Issa, Ibrahim Aldoss, John DiPersio, et al.
Pageof 19

Showing results (131-140 of 189) with videos related to

Sort By:
Pageof 19
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2017
Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance RituximabMatthew G Mei, Thai M Cao, Lu Chen, et al.
Science Translational Medicine|September 27, 2019
CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignanciesHong Qin, Zhenyuan Dong, Xiuli Wang, et al.
Leukemia Research|August 29, 2024
Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantationAmrita Desai, Yazeed Samara, Dongyun Yang, et al.
Bone Marrow Transplantation|August 15, 2024
Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settingsSalman Otoukesh, Dongyun Yang, Sally Mokhtari, et al.
Bone Marrow Transplantation|November 18, 2025
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxisAmandeep Salhotra, Dongyun Yang, Monzr M Al Malki, et al.
Cancer|December 1, 2020
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemiaTalha Badar, Aniko Szabo, Shira Dinner, et al.
Transplantation and Cellular Therapy|July 10, 2026
Impact of prior CAR T-cell treatment on graft-vs-host disease and non-relapse mortality after allogeneic transplantationTamer Othman, Dongyun Yang, Geoffrey Shouse, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 20, 2019
Long-Term Outcomes of Patients with Acute Myelogenous Leukemia Treated with Myeloablative Fractionated Total Body Irradiation TBI-Based Conditioning with a Tacrolimus- and Sirolimus-Based Graft-versus-Host Disease Prophylaxis Regimen: 6-Year Follow-Up from a Single CenterAmandeep Salhotra, Susanta Hui, Dongyun Yang, et al.
Transplantation and Cellular Therapy|May 14, 2023
Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease ProphylaxisJanny M Yao, Salman Otoukesh, Hanna Kim, et al.
Nature|March 16, 2023
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemiaGhayas C Issa, Ibrahim Aldoss, John DiPersio, et al.
Pageof 19